Appropriate Prescribing for older adults with Multimorbidity (Pro-M): protocol for a feasibility study
Background Potentially inappropriate prescribing is common among older adults with multimorbidity due to various reasons, from concurrent application of multiple single-disease clinical guidelines to fragmentation of care. Interventions such as medication review have been implemented worldwide to reduce inappropriate prescribing for older adults. However, the implementability of such interventions are underexplored in the outpatient clinics in Singapore’s public hospitals. Hence, the Pro-M study aims to assess the feasibility of implementing a physician-pharmacist collaborative care intervention in geriatric medicine outpatient clinics to facilitate appropriate prescribing for older adults in Singapore. Methods This is a single-arm, non-randomised feasibility study using a pre-post evaluation design. This study consists of two parts: (1) implementation phase of the intervention (6 months) and an (2) evaluation phase (3 months). Eligible patients will be recruited from geriatric medicine outpatient clinics at two public hospitals in Singapore through convenience sampling. The main components of the Pro-M intervention are: (1) pharmacist-facilitated medication reviews with feedback on any medication issues and potential recommendations to physicians, and (2) physicians communicating changes to other relevant prescribers. The evaluation phase will involve surveying and interviewing physicians and pharmacists involved in the implementation of the intervention. A mixed-method approach will be employed for data collection and analysis. The quantitative and qualitative findings will be triangulated and reported using Proctor’s implementation outcomes: appropriateness, penetration, acceptability, fidelity, feasibility, and sustainability. A basic cost analysis will be conducted alongside the study. Discussion This is a phase 2 study to test the feasibility of implementing an intervention that was co-created with stakeholders during phase 1 development of an intervention to optimise prescribing for older adults with multimorbidity. The implementation will be assessed using Proctor’s implementation outcomes to provide insights on the process and the feasibility of implementing medication reviews for older adults with multimorbidity as a routine practice in outpatient clinics. Data collected from this study will inform a subsequent scale-up study. Trial registration ClinicalTrials.gov Identifier: NCT05756478. Registered on 06 March 2023..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
Archives of public health - 82(2024), 1 vom: 18. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tang, Jia Ying [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Feasibility study |
|---|
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1186/s13690-024-01264-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055200672 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055200672 | ||
| 003 | DE-627 | ||
| 005 | 20240319064718.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240319s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13690-024-01264-x |2 doi | |
| 035 | |a (DE-627)SPR055200672 | ||
| 035 | |a (SPR)s13690-024-01264-x-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Tang, Jia Ying |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Appropriate Prescribing for older adults with Multimorbidity (Pro-M): protocol for a feasibility study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Background Potentially inappropriate prescribing is common among older adults with multimorbidity due to various reasons, from concurrent application of multiple single-disease clinical guidelines to fragmentation of care. Interventions such as medication review have been implemented worldwide to reduce inappropriate prescribing for older adults. However, the implementability of such interventions are underexplored in the outpatient clinics in Singapore’s public hospitals. Hence, the Pro-M study aims to assess the feasibility of implementing a physician-pharmacist collaborative care intervention in geriatric medicine outpatient clinics to facilitate appropriate prescribing for older adults in Singapore. Methods This is a single-arm, non-randomised feasibility study using a pre-post evaluation design. This study consists of two parts: (1) implementation phase of the intervention (6 months) and an (2) evaluation phase (3 months). Eligible patients will be recruited from geriatric medicine outpatient clinics at two public hospitals in Singapore through convenience sampling. The main components of the Pro-M intervention are: (1) pharmacist-facilitated medication reviews with feedback on any medication issues and potential recommendations to physicians, and (2) physicians communicating changes to other relevant prescribers. The evaluation phase will involve surveying and interviewing physicians and pharmacists involved in the implementation of the intervention. A mixed-method approach will be employed for data collection and analysis. The quantitative and qualitative findings will be triangulated and reported using Proctor’s implementation outcomes: appropriateness, penetration, acceptability, fidelity, feasibility, and sustainability. A basic cost analysis will be conducted alongside the study. Discussion This is a phase 2 study to test the feasibility of implementing an intervention that was co-created with stakeholders during phase 1 development of an intervention to optimise prescribing for older adults with multimorbidity. The implementation will be assessed using Proctor’s implementation outcomes to provide insights on the process and the feasibility of implementing medication reviews for older adults with multimorbidity as a routine practice in outpatient clinics. Data collected from this study will inform a subsequent scale-up study. Trial registration ClinicalTrials.gov Identifier: NCT05756478. Registered on 06 March 2023. | ||
| 650 | 4 | |a Feasibility study |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Potentially inappropriate prescribing |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Older adults |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Proctor’s implementation outcomes |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Medication review |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Teng, Poh Hoon June |4 aut | |
| 700 | 1 | |a Chen, Christine Yuanxin |4 aut | |
| 700 | 1 | |a Tan, Keng Teng |4 aut | |
| 700 | 1 | |a Ang, Wendy |4 aut | |
| 700 | 1 | |a Lau, Sabrina |4 aut | |
| 700 | 1 | |a Ang, Alexis Guat Cheng |4 aut | |
| 700 | 1 | |a Kyaw, Kay Khine |4 aut | |
| 700 | 1 | |a Tay, Xin Yong |4 aut | |
| 700 | 1 | |a Lim, Wan Min Stephanie |4 aut | |
| 700 | 1 | |a Espeleta, Wrenzie Del Valle |4 aut | |
| 700 | 1 | |a Lin, Huimin |4 aut | |
| 700 | 1 | |a Ding, Yew Yoong |4 aut | |
| 700 | 1 | |a Lun, Penny |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of public health |d BioMed Central, 1997 |g 82(2024), 1 vom: 18. März |w (DE-627)SPR032169604 |w (DE-600)2133388-9 |x 2049-3258 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2024 |g number:1 |g day:18 |g month:03 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13690-024-01264-x |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2024 |e 1 |b 18 |c 03 | ||